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Abstract
Background: Approximately 1/3 of individuals have a high plasma response to dietary cholesterol
(hyper-responders). Although increases in both LDL and HDL cholesterol have been observed,
limited data exist regarding effects of egg consumption on lipoprotein subclasses and circulating
carotenoids.
Methods: 29 postmenopausal women (50–68 y) and 13 men (60–80 y) were assigned to either 3
eggs (EGG, 640 mg cholesterol/d) or an equal volume of cholesterol-free egg substitute (SUB, 0 mg
cholesterol/d) for 30 d. Following a 3 wk wash out, subjects crossed over to the alternate diet.
Individuals with a response to dietary cholesterol > 2.2 mg/dL for each additional 100 mg of dietary
cholesterol were classified as hyper-responders while hypo-responders were those with a
response ≤ to 2.2 mg/dL. Nuclear Magnetic Resonance (NMR) spectroscopy determined LDL and
HDL size & particle concentrations. Dietary records were used to evaluate carotenoid
consumption.
Results: Hyper-responders had higher concentrations of both LDL (LDL-C) and HDL (HDL-C)
cholesterol after EGG. In contrast, the concentrations of plasma LDL-C and HDL-C did not differ
between the EGG and SUB for the hypo-responders. After EGG, hyper-responders had larger (≥
21.2 nm) less atherogenic LDL particle (P < 0.001) and larger HDL particle (> 8.8 nm) (P < 0.01),
with no significant difference in the total number of LDL or HDL particles. Regardless of response
classification, all individuals had an increase in plasma lutein (from 32.4 ± 15.2 to 46.4 ± 23.3 ng/L)
and zeaxanthin (from 8.8 ± 4.8 to 10.7 ± 5.8 ng/L) during EGG, yet hyper-responders displayed
higher concentrations of carotenoids when compared to hypo-responders
Conclusion: These findings suggest that the increases in LDL-C and HDL-C due to increased egg
consumption in hyper-responders are not related to an increased number of LDL or HDL particles
but, to an increase in the less atherogenic lipoprotein subfractions. Also, increases in plasma
carotenoids after EGG may provide a valuable dietary source for this population.
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In the United States, people are living longer, healthier
lives. Dietary requirements for the elderly must take into
account the physiologic changes that occur with aging as
these needs differ from those of younger adults. Nutri-
tional support in the elderly is often a primary therapy
and it has been shown that those that have an adequate
intake of fatty acids and cholesterol as well as a greater
intake of vitamins demonstrate higher intellectual func-
tion than those who have a deficient diet [1-3].
The habitual consumption of eggs has been shown to pro-
vide many nutritional benefits such as higher daily intakes
of vitamins C, E and B12, in addition to folate [4]. Defi-
ciencies in these vitamins have been associated with
increased risk of cancer, cardiovascular disease and Alzhe-
imer's disease [5-7]. Therefore, the addition of eggs to the
diet could actually prevent disease development, particu-
larly in this age demographic who are at elevated risks for
the onset of chronic diseases. Additionally, current
research has shown that eggs supply a significant amount
of the carotenoids lutein and zeaxanthin, which have
been linked to the prevention of age-related macular
degeneration [8-11], the most common cause of blind-
ness in those over the age of 60. On average, each egg yolk
contains 292 µg of lutein and 213 µg of zeaxanthin, along
with 0.7 mg vitamin E, 0.5 mcg vitamin B12, and 23.5
mcg folate, all in a highly bioavailable food matrix
[12,13].
Because of the nutrient density of eggs, they are valuable
contributors to overall nutritional balance, but they are
also a source of dietary cholesterol. Currently, the rela-
tionship between plasma cholesterol and dietary choles-
terol remains unclear. High serum cholesterol levels have
been linked to increased coronary heart disease (CHD)
[14,15] yet the risk of cardiovascular disease in men and
women does not increase with increasing egg consump-
tion [16-18] despite their high cholesterol content. Sum-
marizing 166 cholesterol feeding studies conducted over
40 years on 3,500 subjects, a 100 mg/d increase in dietary
cholesterol will raise total cholesterol 2.2 mg/dL or about
1% in normal responders [19]. This response relates to a
1.9 mg/dL change in low density lipoprotein (LDL) cho-
lesterol and a 0.4 mg/dL increase in high density lipopro-
tein (HDL) cholesterol, utimately having little effect on
the LDL/HDL cholesterol ratio, and minimal impact on
CHD risk [20]. There is a large variation in response how-
ever, and hyper-responders are classified as those whose
total cholesterol concentration will increase >2.2 mg/dL,
and hypo-responders are those for whom total cholesterol
increases < 2.0 mg/dL, for every 100 mg/d of dietary cho-
lesterol consumed [21]. This heterogeneity in response
confounds the relationship between dietary cholesterol
and plasma cholesterol.
Plasma lipoproteins are comprised of a group of diverse
particles with various physiochemical characteristics that
define each subclass. It is the physiochemical characteris-
tics that determine the degree of atherogenicity of the
lipoprotein particle. In clinical practice, it is the choles-
terol concentration carried in lipoproteins that captures
the attention of the physician. This is the premise behind
the use of the LDL and HDL cholesterol concentration
ratio as an assessment of CHD risk. However, the evalua-
tion of size deviation among lipoprotein subclasses has
shown that normocholesterolemic individuals with a
higher concentration of the small, dense LDL particle are
at increased risk for coronary heart disease [22-24],
despite similar LDL cholesterol concentrations. Similarly,
when analyzing the cholesterol concentration of the HDL
particle, the protective effects are often amplified when
there is a higher concentration the larger subclass (HDL2)
which is more antiatherogenic than the smaller HDL3 par-
ticle [25-28]. It has been documented that a dietary cho-
lesterol challenge does not impact the LDL/HDL ratio in
premenopausal women [29], or in an elderly population
[30] comprised of both genders. In addition, traditional
gel electrophoretic analysis of LDL particle size revealed
that the larger LDL particle was predominant in hyper-
responders during a dietary cholesterol intervention [31].
It can be surmised then that the cholesterol concentration
that each subclass contains can vary by particle size,
number, and density. Traditional lipoprotein cholesterol
measurements, specifically the LDL/HDL ratio, fail to con-
sider the variability in size distribution. This high degree
of variability may therefore lead to inaccurate assessment
of CHD risk.
The Adult Treatment Panel III recently acknowledged that
the predominance of small dense LDL particles (sdLDL) is
an emerging cardiovascular risk factor [32,33]. It has been
reported that LDL size was the best predictor of coronary
artery disease [34,35] and the increase in cardiovascular
risk, attributable to lipid factors, was significantly modu-
lated by variations in LDL particle size [32,36]. Utilizing
nuclear magnetic resonance (NMR) spectroscopy, Blake,
et al [37] found that median baseline values of LDL parti-
cle concentration were higher and LDL particle size was
lower among women who subsequently experienced a
coronary event. These evaluations suggest that the meas-
urement of LDL cholesterol content alone is an inade-
quate marker of CHD risk in the general population. In a
cohort of men from the Quebec Cardiovascular Study, the
association between LDL particle size and the incidence of
ischemic heart disease yielded similar results. In this
study, multivariate analysis indicated that sdLDL particles
predicted the rate of ischemic heart disease independent
of LDL cholesterol content and other lipid risk factors
[38]. This large scale, prospective evidence supports a
hypothesis that LDL particle size is an important charac-Page 2 of 10
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diameter analysis in CHD risk assessment may increase
the accuracy of the evaluation over traditional lipid val-
ues.
Carotenoids and cholesterol share common pathways in
absorption and transport in the plasma compartment as
well as response differences. It is this commonality that
led to this study, whose objectives are to evaluate the
changes in lipoprotein size, cholesterol content and caro-
tenoid concentration in an elderly population following
egg consumption and relate those changes to their impact
on CHD risk assessment.
Methods
Materials
Liquid whole eggs and cholesterol-free, fat-free egg substi-
tute were purchased from Vistar (Windsor, CT). Enzy-
matic TC and triglyceride (TG) kits were obtained from
Roche Diagnostics (Indianapolis, IN). Apolipoproteins
(apo) B kits, EDTA, aprotinin, copper sulfate, sodium
azide, phenylmethlysulfonyl fluoride (PMSF) were
obtained from Sigma Chemical (St. Louis, MO).
Subjects
Recruitment efforts were conducted through the use of
local newspapers and brochure distribution within the
surrounding University community. Men were required to
be over the age of 60 while women were expected to be
menopausal for at least one year. Recruitment of male par-
ticipants was hindered due to the popular use of reductase
inhibitor medication which excluded almost 60% of the
male respondents. Ultimately, forty-two healthy volun-
teers (13 men and 29 women) were recruited with the
exclusion criteria consisting of 1) allergy to eggs, 2) use of
lipid-lowering medication, 3) history of heart disease, dia-
betes or kidney problems, 4) total cholesterol values
higher than 240 mg/dL or total triglyceride levels over 300
mg/dL. The subjects were instructed to continue to con-
sume their regular diet but to abstain from consuming
eggs outside of those provided by the study. The study was
conducted in accordance with the guidelines of the Insti-
tutional Review Board at the University of Connecticut.
Experimental protocol
This study utilized a randomized cross-over design where
subjects were initially assigned to an egg (EGG) or egg
Table 2: VLDL, LDL and HDL Particle Sizes of male and female hyper- and hypo-responders during the EGG and placebo (SUB) 
periods1.
VLDL LDL HDL
(nm)
Hyper-responders (n = 15)
EGG 46.05 ± 8.78 21.77 ± 0.95 9.49 ± 0.55
SUB 48.60 ± 8.55 21.48 ± 0.95 9.35 ± 0.49
Hypo-responders (n = 27)
EGG 47.30 ± 7.39 21.37 ± 0.81 9.19 ± 0.46
SUB 46.94 ± 7.35 21.41 ± 0.80 9.10 ± 0.49
Diet Effect NS2 NS P < 0.01
Response Effect NS NS NS
1 Values are presented as mean ± SD.
2 NS = non-significant
Table 1: Plasma concentrations of total cholesterol LDL-C, HDL-C and TG of male and female hyper- and hypo-responders during the 
EGG and placebo (SUB) periods1
Total Cholesterol LDL-C HDL-C TG
mg/dL
Hyper-responders (n = 15)
EGG 210.6 ± 43.3a 130.8 ± 45.4a 60.3 ± 13.6a 97.5 ± 62.8
SUB 175.6 ± 41.4b 103.4 ± 28.0b 54.6 ± 10.5b 95.3 ± 75.2
Hypo-responders (n = 27)
EGG 178.6 ± 27.6b 101.9 ± 39.4b 55.3 ± 14.9b 99.9 ± 42.2
SUB 181.5 ± 25.7b 106.2 ± 24.6b 54.2 ± 14.5b 106.0 ± 42.5
Diet Effect P < 0.0001 P < 0.0001 P < 0.0001 NS2
Response Effect P < 0.0001 P < 0.0001 P < 0.01 NS
1 Values are shown as the mean ± SD. Values in the same column with different superscript are significantly different as determined by repeated 
measures ANOVA
2 NS = non-significantPage 3 of 10
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week washout period. The subjects were then crossed over
to the alternate dietary intervention and continued for 30
days. Those assigned to the EGG group were expected to
consume 3 eggs per day (approximately 640 mg dietary
cholesterol). Conversely, the SUB group was given an
equal volume of a cholesterol-free, fat-free product almost
identical in color and consistency to the egg product (0
mg dietary cholesterol). Daily amounts were provided in
individual containers and subjects were instructed to
return any uneaten portion at the beginning of the follow-
ing week. To ensure that diets during the intervention
periods were equivalent and to calculate the amounts of
dietary lutein and zeaxanthin, two seven-day dietary
records were collected. Records included two weekend
days and five non-consecutive weekdays. Nutrient intake
was evaluated using Nutritional Data Systems software
(NDS-R) Version 5.0, developed by the Nutrition Coordi-
nating Center, University of Minnesota, Minneapolis,
MN, Food and Nutrient Database 29. The variables of
weight, waist and hip circumference, smoking and hor-
mone replacement status were also measured at baseline
and at the end of each treatment period to assess the influ-
ence these factors may have had on plasma lipids and
lipoprotein characteristics.
Two fasting (12 h) blood draws were scheduled at the end
of each intervention period, on non-consecutive days, 48
hours apart, for each subject. Whole blood was collected
into tubes containing 0.10 mL/100 mL EDTA to deter-
mine plasma lipids. Plasma was separated by centrifuga-
tion at 1500 × g for 20 min at 4°C, and placed into vials
containing PMSF (0.05 mL/100 mL), sodium azide (0.01
mL/100 mL) and aprotinin (0.01 mL/100 mL) and stored
at 4°C until analysis. Plasma lipid analysis occurred
within one week of collection.
Classification of hyper- and hyporesponders
As previously described [39], a modest increase in total
cholesterol of 0.05 – 0.06 mmol/L (2–2.2 mg/dL) may be
considered a normal response to a 100 mg dietary choles-
terol challenge. Therefore, because the subjects consumed
an additional 640 mg/d of dietary cholesterol, those that
had an increase in total cholesterol (TC) of ≥ 0.41 mmol/
L (16 mg/dL) were labeled hyper-responders and those
whose fluctuations in TC were ≤ 0.36 mmol/L (14 mg/
dL), were identified as hypo-responders [29,40,41].
Plasma lipids
Since 1989 our laboratory has participated in the Center
for Disease Control/National Heart, Lung and Blood
Institute (CDC-NHLBI) lipid standardization program for
quality control and standardization of plasma TC, TG and
HDL-C assays. The coefficients of variance assessed by the
standardization program during this study were 0.76–
1.2% for TC, 1.64 – 2.47% for TG and 1.71 – 2.27% for
HDL-C. Plasma lipids were determined by averaging three
values obtained from the separate blood draws.
Analysis included enzymatic TC, as described by Allain et
al [42] and triglyceride (TG) calculations [43] with kits
from Roche Diagnostics that adjust for free glycerol. High
density lipoprotein cholesterol content (HDL-C) was
evaluated after the precipitation of apolipoprotein-B con-
taining particles with a magnesium chloride and dextran
sulfate solution [44]. Low density lipoprotein cholesterol
content (LDL-C) was determined using the Friedewald
equation [45].
Plasma lutein and Zeaxanthin determinations
Plasma (200 µl) was prepared for HPLC analysis by com-
bining each sample with an internal standard of 50 µl
ethyl-β-apo-8'-carotenoate (Fluka, Ronkonkoma, NY)
and 200 µl ethanol containing butylated hydroxytoluene,
similar to the method previously described [46]. Briefly,
the sample was extracted three separate times using a hex-
ane carrier containing butylated hydroxytoluene while
centrifugation facilitated the phase separation. The sol-
vent was removed with a stream of nitrogen and the
resulting hexane layers were reconstituted with 100 µl of
2-propanol and placed into HPLC injection vials. A
Waters HPLC system equipped with a Varian column (100
× 4.6 mm Microsorb-MN 100-3 C-18), and preceded by
an Upchurch C-18 guard column (Upchurch Scientific,
Oak Harbor, WA) was used to analyze the carotenoid con-
tent of the plasma. The isocratic mobile phase contained
80% acetonitrile, 15% dioxane, 2.5% methanol, 2.5% 2-
propanol, 0.01% triethylamine, and 0.01% ammonium
acetate. The internal standard and carotenoid content of
the plasma was detected at 450 nm. All solvents were
HPLC grade and were filtered and degassed before use.
Changes in HDL particle size as a result in egg consumptionFigur  1
Changes in HDL particle size as a result in egg consumption. 
Each bar represents one subject.
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and zeaxanthin.
Lipoprotein size determinations
Based on the natural proton NMR profiles of lipoprotein
particles, a spectroscopic alternative to separation-based
methodology was utilized to analyze lipoprotein sub-
classes [47-49]. This analysis took place at Liposcience,
Inc. and will be briefly described here. An intermediate
field (400 MHz) NMR analyzer (Bruker BioSpin Corp,
Billerica, MA) with an automated flow-injection process
was used to measure the lipoprotein subclasses in plasma
samples. The deviations to be seen between lipoprotein
subclasses are the result of the diameter of the phospholi-
pid shell of the particle and are not influenced by apolipo-
proteins contained within the shell. The amplitude of
each particle's signal is a measure of the concentration of
the lipoprotein subclass. NMR simultaneously quantifies
> 30 lipoprotein subclasses that were empirically grouped
into 10 smaller subclasses based on particle diameter. The
ten subclasses analyzed in this study were large VLDL (>60
nm), medium VLDL (35–60 nm), small VLDL (27 – 35
nm), large LDL (21.2 – 23 nm), medium LDL (19.8 – 21.2
nm), small LDL (18 – 19.8 nm), very small LDL (16.8 –
18 nm), large HDL (8.8 – 13 nm), medium HDL (8.2 –
8.8 nm) and small HDL (7.3 – 8.2 nm).
Statistical analysis
Repeated measures analysis of variance (ANOVA) was
used to analyze the effects of egg consumption on plasma
lipids, HDL, VLDL, and LDL particle characteristics and
lutein and zeaxanthin concentrations. Each individual's
response to diet (egg or substitute) was considered as the
repeated measure with the response classification used as
the between subject factor. P < 0.05 was considered signif-
icant. Data are presented as means ± SDs for the number
of subjects in each group. Statistical analysis was con-
ducted using SPSS v. 12 for Windows (SPSS, Chicago).
Results
Study population characteristics
There was no difference between hyper- and hypo-
responders with respect to baseline values of TC, LDL-C,
and TG or body mass index (data not shown). Body mass
index values did not differ between response groups dur-
ing the EGG or SUB periods (Hyper-responders; 27.3 +
6.3 EGG, 26.9 + 5.9 SUB: Hypo-responders; 27.2 + 4.7
EGG, 27.2 + 4.9 SUB)
Plasma lipid concentrations
Plasma concentrations for the hyper-responders showed
significant diet effects on plasma lipids (Table 1). Total
cholesterol, LDL-C and HDL-C were higher after the EGG
period compared to the SUB period for hyper-responders
(P < 0.0001) (Table 1). In contrast, total cholesterol, LDL-
C or HDL-C were not different between the EGG and SUB
period for hypo-responders. There was no statistical sig-
nificance to changes in triglycerides as a result of diet or
response effects during this study (Table 1).
Lipoprotein particle size
Comparison of the average VLDL, LDL and HDL particle
size in hyper- and hypo-responders revealed statistical sig-
nificance only for HDL showing a larger HDL particle seen
during the EGG treatment period for both hyper and
hypo-responders (Table 2). VLDL and LDL particle size
was not affected by diet or response classification. The
changes in HDL size as a result of egg consumption are
indicated in Fig. 1. As seen in the figure the majority of the
subjects had an increase in HDL particle size following
EGG period, independent of response classification.
Individual subclass analysis of the concentration of LDL
particles showed a significant increase in the larger LDL
particle during the EGG treatment period for hyper-
responders (Table 3). Particle concentration of the large
LDL subclass was 674.7 ± 258.4 µmol/L during the EGG
Table 3: Concentration of total LDL and LDL sub-fractions of male and female hyper- and hypo-responders during the EGG and 
placebo (SUB) periods1.
Total LDL Large LDL Medium LDL Small LDL Very Small LDL
(nmol/L)
Hyper-responders (n = 15)
EGG 1241 ± 633. 674.7 ± 258.4a 101.5 ± 127.3 525.9 ± 696.0 491.7 ± 355.7
SUB 1186 ± 529 521.1 ± 267.3b 130.7 ± 134.0 629.3 ± 633.9 517.4 ± 321.2
Hypo-responders (n = 27)
EGG 1217 ± 320 543.3 ± 252.2b 128.7 ± 86.6 637.3 ± 426.0 424.3 ± 570.1
SUB 1209 ± 356 548.1 ± 229.4b 124.4 ± 82.0 624.6 ± 415.9 498.3 ± 501.2
Diet Effect NS2 P < 0.0001 NS NS NS
Response Effect NS P < 0.0001 NS NS NS
1 Values are shown as the mean ± SD. Values in the same column with different superscript are significantly different as determined by repeated 
measures ANOVA
2 NS = non-significantPage 5 of 10
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for hyper-responders for a diet effect of P < 0.0001. Com-
paring response classifications, it was noted that hyper-
responders had an increased concentration of the larger
LDL particle (674.7 ± 258.4 µmol/L for EGG period) than
the concentrations in hypo-responders (543.3 ± 252.2
µmol/L for EGG period) demonstrating a significant
response effect. The changes in the large LDL subclass due
to egg intake are illustrated in Fig. 2. The diet effect and
the response effect in increasing LDL size are clearly
depicted for all subjects.
The concentration of HDL particles also showed a signifi-
cant response effect as hyper-responders had an increase
in the larger HDL particle concentration when compared
to hypo-responders (Table 4). There were no differences
seen for hypo-responders in HDL subclass particle sizes
when comparing dietary interventions.
Carotenoid analysis
Analysis of the dietary carotenoids, lutein and zeaxanthin,
yielded a significant diet effect as there was an increased
consumption of both carotenoids during the EGG treat-
ment period. Dietary amounts were 4655 ± 1989 µg and
3429 ± 2003 µg for hyper-responders during the EGG and
SUB treatment periods, respectively, while hypo-respond-
ers consumed 4857 ± 3048 µg during the EGG period and
2755 ± 1608 µg during the SUB treatment (Table 5)
Plasma evaluation of these carotenoids also revealed a
diet effect in lutein and zeaxanthin concentrations as all
subjects increased plasma levels during the EGG period
(Table 5). Although absolute plasma concentrations for
zeaxanthin were lower than lutein, the response was sim-
ilar with an increased plasma concentration seen during
the EGG treatment period with significant elevation noted
in the hyper-responders for both carotenoids. A signifi-
cant correlation between HDL size and plasma lutein (r =
0.361, P < 0.05) and zeaxanthin (r = 0.321, P < 0.05) was
observed for all subjects during the egg period (Fig. 3)
indicating that the higher concentration of plasma carote-
noids were related to the larger HDL following egg intake.
Discussion
While there is little doubt that there exists a continuum of
increasing risk for developing CHD with increasing
plasma cholesterol concentrations, there is uncertainty in
the mechanisms that link hypercholesterolemia and
atherosclerosis. For any given LDL cholesterol concentra-
tion there is great variability in the clinical expression of
the disease. Patients with heterozygous familial hypercho-
lesterolemia exhibit a wide array of ages at which they
develop CHD and even patients with homozygous famil-
ial hypercholesterolemia may differ by as much as 30
years in the age at which CHD is clinically expressed [50].
This striking variability implies a complex and multifac-
eted mechanism between LDL cholesterol and the devel-
opment of atherosclerosis. Clearly, the consideration of
plasma cholesterol alone or ratios that consider only the
cholesterol content of lipoproteins are inadequate indica-
tors of CHD risk. Because the cholesterol content of the
LDL subclass varies with particle size and number, and is
derived by calculation not direct measurements, the
inherent use of this value in the estimation of CHD risk is
fraught with errors. The expression of multiple distinct
LDL subclasses which differ in pathogenic roles, offers the
opportunity to classify the particle based on its pheno-
type. Previous studies have suggested that sdLDL are part
of a cluster of dyslipidemias, termed the atherogenic lipo-
protein phenotype [51]. Prospective work has also
reported that the sdLDL phenotype is a significant predic-
tor of CVD [34,36,52]. It stands to reason then that an
evaluation of particle size and number should be included
in the assessment of CHD risk. In this study, with an ele-
vation of plasma cholesterol as a result of the dietary inter-
vention in the hyper-responders, the analysis of not only
changes in lipoprotein cholesterol content but also size
and number of lipoprotein subclasses were useful to elu-
cidate the mechanisms behind the changes seen in TC lev-
els.
While a significant diet effect was seen in TC, LDL and
HDL cholesterol for hyper-responders during the EGG
period, it is valuable to note that there was a concomitant
increase in the large LDL particle concentration in this
sub-population. Elevated levels of large LDL are classified
as Pattern A and are considered less atherogenic. The
smaller LDL phenotype, Pattern B, is considered more
Changes in concentration of the large LDL subclass due to egg con umption and classification responseFi ur  2
Changes in concentration of the large LDL subclass due to 
egg consumption and classification response. Each bar repre-
sents one hyper (blue bars) or hypo (yellow bars).
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nized as a strong coronary risk factor independent of tra-
ditional lipoprotein cholesterol ratios [53]. If the small,
dense LDL particle is considered pro-atherogenic, as doc-
umented elsewhere, then changes in the large LDL particle
may be considered less atherogenic in this population.
This implies that the relationship between changes in
plasma cholesterol levels and increases in CHD risk is
incomplete and that the modification of the lipoprotein
particle outside of its cholesterol concentration is critical
to the understanding of the mechanism behind elevated
TC. By measuring the particle size and number, through
the efficient NMR technology, we can now visualize the
metabolic processes that might occur during a dietary cho-
lesterol challenge and speculate on the mechanisms
involved. Because the LDL cholesterol content increased
significantly, it was important to analyze the subclass of
LDL particle that carried the changes in cholesterol con-
centration. NMR data indicated that only the larger LDL
particle increased during the EGG period with hyper-
responders demonstrating a significantly larger increase
than hypo-responders. A larger, more buoyant LDL parti-
cle is hypothesized to have a reduced susceptibility to
both oxidation and endothelial penetration. This suggests
that a less atherogenic LDL particle is responsible for the
increase in LDL cholesterol seen in this study.
Similarly, HDL cholesterol content was elevated during
the EGG period for hyper-responders. HDL is considered
the 'good' cholesterol and elevations in this lipoprotein
are generally considered antiatherogenic. This too, relates
to the functionality of the particle as the HDL particle
serves to remove excess cholesterol from the body and
return it to the liver for excretion. Analyzing the particle
size of the major classes of lipoproteins, this study shows
that there was a significant increase in HDL lipoprotein
size as a result of the EGG treatment, where VLDL and LDL
showed no significant changes. The analysis of HDL sub-
classes demonstrated a significant increase in the large
HDL particle for hyper-responders. This indicates a cardi-
oprotective effect in this population as the larger HDL par-
ticle has been correlated with decreased CHD risk [54].
Hyper-responders are classically defined as individuals
who react to dietary cholesterol with a large increase in
plasma cholesterol. The response shown here indicates
that a portion of the increase in TC is associated with an
Table 5: Dietary and plasma concentrations of lutein + zeaxanthin of male and female hypo- and hyper-responders during the EGG and 
placebo (SUB) periods
Dietary Lutein + Zeaxanthin Plasma Lutein Plasma Zeaxanthin
(nm) (µg/dL) (µg/ml)
Hyper-responders (n = 15)
EGG 4655 ± 1989a 55.3 ± 26.3a 14.3 ± 6.7a
SUB 3429 ± 2003b 35.3 ± 16.6c 10.5 ± 6.4b
Hypo-responders (n = 27)
EGG 4857 ± 3048a 41.5 ± 20.3b 8.7 ± 4.0b
SUB 2755 ± 1608b 30.7 ± 14.4c 7.8 ± 3.5c
Diet Effect P < 0.0001 P < 0.0001 P < 0.01
Response Effect NS P < 0.05 P < 0.05
1 Values are shown as the mean ± SD. Values in the same column with different superscript are significantly different as determined by repeated 
measures ANOVA
2 NS = non-significant
Table 4: Concentration of total HDL and HDL sub-fractions of male and female hyper- and hypo-responders during the EGG and 
placebo (SUB) periods1.
Total HDL Large HDL Medium HDL Small HDL
µmol/L
Hyper-responders (n = 15)
EGG 34.3 ± 7.1 10.44 ± 5.07a 3.06 ± 4.54 20.83 ± 3.74
SUB 33.1 ± 5.2 8.47 ± 3.58b 3.86 ± 3.99 20.76 ± 3.75
Hypo-responders (n = 27)
EGG 35.6 ± 6.6 8.70 ± 3.90b 2.40 ± 2.45 24.58 ± 5.05
SUB 36.6 ± 7.1 8.90 ± 4.89b 1.94 ± 2.05 25.79 ± 6.11
Diet Effect NS2 NS NS NS
Response Effect NS P < 0.025 NS NS
1 Values are shown as the mean ± SD. Values in the same column with different superscript are significantly different as determined by repeated 
measures ANOVA
2NS = non-significantPage 7 of 10
(page number not for citation purposes)
Nutrition & Metabolism 2006, 3:6 http://www.nutritionandmetabolism.com/content/3/1/6increase in the larger, antiatherogenic HDL particle and
would therefore offset the effects of increases in LDL cho-
lesterol. We surmise from this that egg consumption will
increase the cardioprotective HDL subclasses as a means
of managing the dietary cholesterol and of balancing cho-
lesterol homeostasis in these elderly subjects.
The lipid content of the yolk provides a highly bioavaila-
ble matrix for the absorption of lutein and zeaxanthin
[12]. Because the SUB diet did not contain additional
lutein and zeaxanthin, these carotenoids where found to
significantly increase in the plasma as a result of the EGG
treatment. Interestingly, hyper-responders had a larger
increase in carotenoid plasma response, mimicking their
elevated cholesterol response. This suggests a common
pathway, given that both cholesterol and these caroten-
oids where elevated as a result of the administration of
this diet. The chemical characteristics of lutein and zeax-
anthin would not allow incorporation into the hydropho-
bic core of lipoproteins but instead permit the free
association with the lipoprotein phospholipid shell. It is
known that these carotenoids are carried primarily in the
HDL subclass [55-57] and we have shown that the larger
HDL is increasing as a result of this intervention. We sus-
pect that some of the increased carotenoid intake has
found its way into the plasma compartment coincident
with the changes to the HDL particle by means of the
reverse cholesterol transport system. Due to the location
of lutein and zeaxanthin on the surface of lipoproteins, it
is possible that these carotenoids could exchange during
particle remodeling, while HDL interacts with other lipo-
proteins in the plasma compartment. There is tissue spe-
cificity with respect to lutein and zeaxanthin
concentration with the macular pigment having the great-
est concentration[46]. Because plasma levels of these car-
otenoids increase following changes in diet and
Correlation between large HDL concentrations and plasma lutein for all subjects during the egg periodFigure 3
Correlation between large HDL concentrations and plasma lutein for all subjects during the egg period.
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Nutrition & Metabolism 2006, 3:6 http://www.nutritionandmetabolism.com/content/3/1/6supplementation, it is proposed that the antioxidant
nature of these carotenoids could serve to decrease the
oxidative stress potential found in the plasma compart-
ment and thereby reduces oxidative damage. This is the
hypothesis behind the use of lutein and zeaxanthin in the
prevention of macular degeneration and might also repre-
sent the mechanism by which they could offer cardiopro-
tective effects.
Conclusion
Taken together these findings suggest that (1) LDL particle
numbers do not significantly increase despite an increase
in LDL-C with egg consumption; and (2) lipoprotein size
is positively altered by the consumption of three eggs per
day in elderly subjects. The data shown here displays a sig-
nificant increase in the larger LDL and HDL particles for
hyper-responders, which suggests an antiatherogenic pro-
file. In addition, the increase in plasma lutein and zeaxan-
thin following egg consumption may provide a valuable
source of functional carotenoids in the diet for the popu-
lation. Within the nutritional community there is a devel-
oping appreciation that health derives, not from
avoidance of particular foods, but from an overall pattern
of diet, and it has been suggested that dietary recommen-
dations should shift from one of avoidance to promotion.
This study suggests that egg consumption may be permit-
ted, and perhaps promoted, in a healthy elderly popula-
tion to supplement carotenoid intake with minimal
reservations concerning coronary heart disease risk.
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